产品: 磷酸化 CREB (Ser133) 抗体
货号: AF3189
描述: Rabbit polyclonal antibody to Phospho-CREB (Ser133)
应用: WB IHC IF/ICC
文献验证: WB, IHC, IF/ICC
反应: Human, Mouse, Rat
预测: Pig, Bovine, Horse, Sheep, Rabbit, Dog, Chicken, Xenopus
蛋白号: P16220
RRID: AB_2834621

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1040 1300 现货
 100ul RMB¥ 1920 2400 现货
 200ul RMB¥ 3200 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:2000, IHC 1:100-1:500, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user. For optimal experimental results, antibody reuse is not recommended.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Mouse, Rat
克隆:
Polyclonal
特异性:
Phospho-CREB (Ser133) Antibody detects endogenous levels of CREB only when phosphorylated at Serine 133.
RRID:
AB_2834621
引用格式: Affinity Biosciences Cat# AF3189, RRID:AB_2834621.
偶联:
Unconjugated.
纯化:
The antibody is from purified rabbit serum by affinity purification via sequential chromatography on phospho-peptide and non-phospho-peptide affinity columns.
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

Active transcription factor CREB; cAMP response element binding protein 1; cAMP response element binding protein; cAMP responsive element binding protein 1; cAMP-responsive element-binding protein 1; CREB; CREB-1; CREB1; CREB1_HUMAN; Cyclic AMP-responsive element-binding protein 1; MGC9284; OTTHUMP00000163864; OTTHUMP00000163865; OTTHUMP00000206660; OTTHUMP00000206662; OTTHUMP00000206667; Transactivator protein;

抗原和靶标

免疫原:

A synthesized peptide derived from human CREB around the phosphorylation site of Ser133.

基因/基因ID:
描述:
This gene encodes a transcription factor that is a member of the leucine zipper family of DNA binding proteins. This protein binds as a homodimer to the cAMP-responsive element, an octameric palindrome.

研究领域

· Environmental Information Processing > Signal transduction > cGMP-PKG signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > cAMP signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > PI3K-Akt signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > AMPK signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > TNF signaling pathway.   (View pathway)

· Human Diseases > Endocrine and metabolic diseases > Insulin resistance.

· Human Diseases > Neurodegenerative diseases > Huntington's disease.

· Human Diseases > Substance dependence > Cocaine addiction.

· Human Diseases > Substance dependence > Amphetamine addiction.

· Human Diseases > Substance dependence > Alcoholism.

· Human Diseases > Infectious diseases: Bacterial > Tuberculosis.

· Human Diseases > Infectious diseases: Viral > Hepatitis B.

· Human Diseases > Infectious diseases: Viral > Human papillomavirus infection.

· Human Diseases > Infectious diseases: Viral > HTLV-I infection.

· Human Diseases > Cancers: Overview > Viral carcinogenesis.

· Human Diseases > Cancers: Specific types > Prostate cancer.   (View pathway)

· Organismal Systems > Aging > Longevity regulating pathway.   (View pathway)

· Organismal Systems > Circulatory system > Adrenergic signaling in cardiomyocytes.   (View pathway)

· Organismal Systems > Development > Osteoclast differentiation.   (View pathway)

· Organismal Systems > Immune system > Antigen processing and presentation.   (View pathway)

· Organismal Systems > Environmental adaptation > Circadian rhythm.   (View pathway)

· Organismal Systems > Environmental adaptation > Circadian entrainment.

· Organismal Systems > Nervous system > Cholinergic synapse.

· Organismal Systems > Nervous system > Dopaminergic synapse.

· Organismal Systems > Endocrine system > Insulin secretion.   (View pathway)

· Organismal Systems > Endocrine system > Estrogen signaling pathway.   (View pathway)

· Organismal Systems > Endocrine system > Melanogenesis.

· Organismal Systems > Endocrine system > Thyroid hormone synthesis.

· Organismal Systems > Endocrine system > Glucagon signaling pathway.

· Organismal Systems > Endocrine system > Renin secretion.

· Organismal Systems > Endocrine system > Aldosterone synthesis and secretion.

· Organismal Systems > Endocrine system > Relaxin signaling pathway.

· Organismal Systems > Excretory system > Vasopressin-regulated water reabsorption.

文献引用

1). Targeting P2Y14R protects against necroptosis of intestinal epithelial cells through PKA/CREB/RIPK1 axis in ulcerative colitis. Nature communications, 2024 (PubMed: 38453952) [IF=16.6]

2). Neuropeptide Precursor VGF Promotes Neuroendocrine Differentiation and Cancer-Associated Fibroblast Activation in Small Cell Lung Cancer. Cancer research, 2025 (PubMed: 40857617) [IF=12.5]

Application: WB    Species: human    Sample: NCI-H82 cell

Figure 3. VGF drives NE differentiation of SCLC-A by activating CREB signaling and upregulating ASCL1. A, Volcano plot showing DEGs in NCI-H128 cells following VGF knockdown (shVGF) compared with negative control (NC). Down, downregulated; FC, fold change; NotSig, not significant; Up, upregulated. B, Venn diagram showing overlapping downregulated genes in NCI-H128 cells after VGF knockdown and in non–SCLC-A cells compared with SCLC-A cells, using data from the Cancer Cell Line Encyclopedia database. C, Western blot analysis of VGF, pCREB, CREB, and TOX3 in NCI-H128 cells following VGF knockdown. D, Co-IP assay demonstrating the interaction between CREB and TOX3 after TLQP-21 (10 µmol/L) stimulation for 24 hours. E, Comparison of potential transcription factors for ASCL1 from ChIP-seq databases and transcription factor prediction databases. F, ChIP–qPCR analysis of CREB binding to the ASCL1 promoter following TLQP-21 (10 µmol/L) stimulation for 24 hours. G, Predicted CREB-binding motif on the ASCL1 promoter using the JASPAR database, with the mutant site highlighted in red. H, Dual-luciferase reporter assay assessing CREB-driven transcription of ASCL1 after mutating the binding motif and TLQP-21 (10 µmol/L) stimulation for 24 hours. I, Dual-luciferase reporter assay assessing CREB-driven transcription of ASCL1 following treatment with SB290157 (4 µmol/L) or 666-15 (100 nmol/L) alongside TLQP-21 (10 µmol/L) stimulation for 24 hours. MUT, mutant; WT, wild-type. J, Western blot analysis of pCREB, CREB, ASCL1, CHGA, and SYP in NCI-H82 cells following TLQP-21 (10 µmol/L) stimulation or VGF overexpression. K, Western blot analysis of VGF, pCREB, CREB, ASCL1, CHGA, and SYP in NCI-H82 cells following CREB overexpression. L, RT-qPCR analysis of ASCL1, CHGA, and SYP mRNA levels in NCI-H128 and NCI-H82 cells following TLQP-21 (10 µmol/L) stimulation, SB290157 (4 µmol/L), or 666-15 (100 nmol/L) treatment for 24 hours. M, Western blot analysis of pCREB, CREB, ASCL1, CHGA, and SYP in SCLC cells following TLQP-21 (10 µmol/L) stimulation, SB290157 (4 µmol/L), or 666-15 (100 nmol/L) treatment for 24 hours. N, Western blot analysis of pCREB, CREB, ASCL1, CHGA, and SYP in SCLC cells treated with CM from NCI-H128 cells with high VGF expression, SB290157 (4 µmol/L), or 666-15 (100 nmol/L) for 24 hours. Differences between groups were assessed using the unpaired t test. *, P < 0.05; **, P < 0.01; ***, P < 0.001. n = 3. Data are presented as the means ± SEM.

3). The brain-protective mechanism of fecal microbiota transplantation from young donor mice in the natural aging process via exosome, gut microbiota, and metabolomics analyses. Pharmacological research, 2024 (PubMed: 39053865) [IF=9.1]

Application: WB    Species: Mouse    Sample:

Fig. 3. The cerebral protection effects of FMT in mice against age-associated proteins expression levels. (A, B) Quantified protein levels of the cell cycle arrest related proteins of p53, p21, p16/p14, and Rb in mice hippocampus tissues. Data are shown as the mean ± SD, n = 3 per group. Significance was determined by one-way ANOVA followed by the Dunnett T3 test for comparison of multiple groups, *P < 0.05, **P < 0.01, and ***P < 0.001. (C, D) Quantified protein levels of the DNA damage-related protein ATM, and the cognitive-related proteins synapsin I, synaptophysin and PSD95 in mice hippocampus tissues. Data are shown as the mean ± SD, n = 3 per group. Significance was determined by one-way ANOVA followed by the Dunnett T3 test for comparison of multiple groups, *P < 0.05, **P < 0.01, and ***P < 0.001. (E, F) Quantified protein levels of the cell senescence-related proteins CREB, p-CREB, ERK, p-ERK, AKT, p-AKT in mice hippocampus tissues. Data are shown as the mean ± SD, n = 3 per group. Significance was determined by one-way ANOVA followed by the Dunnett T3 test for comparison of multiple groups, *P < 0.05, **P < 0.01, and ***P < 0.001. (G, H) Quantified protein levels of the c-H2AX and TP53BP1 proteins in bone marrow mesenchymal stem cells. Data are shown as the mean ± SD, n = 3 per group. Significance was determined by one-way ANOVA followed by the Dunnett T3 test for comparison of multiple groups, *P < 0.05, **P < 0.01, and ***P < 0.001. (I, J) Quantified protein levels of the β-galactosidase, c-H2AX, and TP53BP1 proteins in in mice hippocampus tissues. Data are shown as the mean ± SD, n = 3 per group. Significance was determined by one-way ANOVA followed by the Dunnett T3 test for comparison of multiple groups, *P < 0.05, **P < 0.01, and ***P < 0.001.

4). CGRP-releasing PLGA/nHA/GO composite microspheres enhance distraction osteogenesis via activation of the cAMP/PKA/CREB pathway. Materials today. Bio, 2025 (PubMed: 40893374) [IF=8.7]

Application: WB    Species: Rat    Sample:

Fig. 5. Molecular Mechanism Analysis (A) Intracellular cAMP concentration measured by ELISA after 30 min of treatment, normalized to total protein content (n = 3). (B–D) Western blot analysis and quantitative assessment of PKA and CREB phosphorylation levels. (B) Representative Western blot images showing p-PKA (Thr197), total PKA, p-CREB (Ser133), total CREB, and GAPDH expression. (C) Quantitative analysis of p-PKA/total PKA ratio. (D) Quantitative analysis of p-CREB/total CREB ratio. (E) qRT-PCR analysis of osteogenic-related gene mRNA expression after 7 days of osteogenic induction. Relative expression levels of Runx2, Osx, OPN (Spp1), OCN (Bglap), and CyclinD1 normalized to Gapdh internal control using 2^-ΔΔCt^ method (n = 3). (F) Representative Western blot images showing expression of osteogenic proteins Runx2, Osx, OPN, OCN, CyclinD1, and GAPDH loading control. (G) Quantitative analysis of protein expression levels normalized to GAPDH (n = 3).

5). Activation of RXRα mitigates maternal separation-induced hippocampal neurodevelopmental impairment in mice by inhibiting oxidative stress and restoring mitochondrial homeostasis. Free radical biology & medicine, 2025 (PubMed: 41275931) [IF=7.1]

6). The critical role of ROS in Ermanin-induced melanogenesis. Free radical biology & medicine, 2021 (PubMed: 34560247) [IF=7.1]

7). CXCR4 influences PUFA desaturation and oxidative stress injury in experimental prostatitis mice by activating Fads2 via PPARγ. Free radical biology & medicine, 2024 (PubMed: 39094710) [IF=7.1]

8). A possible mechanism to the antidepressant-like effects of 20 (S)-protopanaxadiol based on its target protein 14-3-3 ζ. Journal of Ginseng Research, 2022 (PubMed: 36090685) [IF=6.8]

Application: WB    Species: Rat    Sample:

Fig. 5 Effects of fluoxetine (FLU) or PPD on the immobility time in the forced swimming test (FST) (A) and tail suspension test (TST) (B) in the corticosterone (CORT)-induced depression model. Representative Western blot images of GSK 3β, p-Ser9 GSK 3β, CREB, p-Ser133 CREB, BDNF, and β-actin expression levels (C). Western blot analysis showing relative protein levels of p-Ser133 CREB (D), p-Ser9 GSK 3β (E), and BDNF (F). ∗p < 0.05 vs. the control group, nsno statistical significance vs. the control group, #p < 0.05 vs. the CORT group.

9). β-Eudesmol in Rhizoma Atractylodis targets AVPR2 to inhibit the cAMP-AQP2 pathway and promote fluid metabolism. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2025 (PubMed: 40618492) [IF=6.7]

10). Uncaria rhynchophylla ameliorates unpredictable chronic mild stress-induced depression in mice via activating 5-HT1A receptor: Insights from transcriptomics. PHYTOMEDICINE, 2021 (PubMed: 33360346) [IF=6.7]

Application: WB    Species: mice    Sample: hippocampus

Fig. 11. Effects of URE on 5-HT1A signaling pathway. (A) Western blotting analysis of 5-HT1A, BDNF, p-CREB, CREB, p-PKA, and PKA in hippocampus. (B-E) Quantitative data of 5-HT1A (B), BDNF (C), p-CREB/CREB (D), and p-PKA/PKA (E), data represent mean ± SEM (n = 3), ** p < 0.01, *** p < 0.001 vs. the control group; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. the UCMS group. (F) The agonistic effect of URE against 5-HT1A receptor.

加载更多

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.